Dr. Yulia Orlova explains how a new migraine drug works

Published: May 26th, 2018

Category: MBI News

Pain from migraine headaches is a major cause of disability. OrlovaIn the U.S. one in seven adults are affected by migraine. The FDA recently approved a novel treatment that could help prevent them, in some cases.

In The Conversation, UF Health neurologist and MBI member Yulia Orlova, M.D., Ph.D., D.Med.Sc., discusses how this new drug works.

Click here to read Orlova’s article in The Conversation